With the Fed’s pivot now well understood and appreciated, investor attention now turns to growth which is slowing faster and more than expected. Defensives have been leading since mid-November, and that’s likely to continue until PMIs and earnings revisions trough. Winter is here…Investor attention should now turn away from the Fed and to the Ice part of our narrative –…
Morgan Stanley: Weekly Warm-up: Winter Is Here, Keep Playing Defense
A financial market resource for the every-day investor and trader.
-
Follow The Data Into The Worst Weeks
Seth Golden, , Research Reports, 0
Hindsight is 20/20, as they say, but regret is front of mind and stickier than even inflation proposes. When...
-
-
J.P. Morgan on NVIDIA Corporation: Strong Results/Guide On AI Demand Pull For Datacenter Compute/Networking Products; Software Sales Accelerating; Reit OW
Seth Golden, , Research Reports, 0
NVIDIA reported Oct results (revenue/GMs/EPS ) well above consensus and off of a higher Oct-Qtr revenue base, the team...
-
J.C. Penney Q4 2017 Review
Seth Golden, , Research Reports, 0
After a rather rocky road traveled in the first half of 2017, J.C. Penney sales results improved dramatically in...
-
Merrill Lynch: Treasury Offsetting QT Until Mid-2023
Seth Golden, , Research Reports, 0
Chief Investment Office Macro Strategy Team at Merrill Lynch: Macro Strategy—Treasury Offsetting QT Until Mid-Year: The looming debt ceiling...
-
Morgan Stanley: Reaching Herd Immunity
Seth Golden, , Research Reports, 0
When can the US achieve broad vaccination of its population: Using the current rate of daily vaccinations (red line,...
-
Market History Guides as VIX Finally Breaks Below 20
Seth Golden, , Research Reports, 0
The strong start to the year for risk assets was upended in the final week of January, as the...
-
Weekly State of the Market: Bubble, Bubble… Where?
Seth Golden, , Research Reports, 0
The most painful thing to watch with traders is the belief that markets have to prove something to THEM,...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00